Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2018 · 10-Q
Revenue$731.00K$731.00K+23.7% vs Q1 2017 Net Income-$4.41M-$4.41MN/M vs Q1 2017 EPS Diluted-$0.73-$0.73N/M vs Q1 2017 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flow-$4,119,000N/M Free Cash Flowderived-$4,172,000N/M Margins · derivedGross margin20.8%+41.9 pt vs Q1 2017
Operating margin-595.3%+610.9 pt vs Q1 2017
Net margin-603.1%+673.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 11, 2018 · 41 d after period end